Get started
Author

Seema Nair Parvathy

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
2023 · Bertrand Routy, John G. Lenehan, et al. · Nature Medicine · 516
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
2022 · Hongchao Pan, Richard Peto, et al. · The Lancet · 394
PDF
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial
2020 · Laura Craven, Adam Rahman, et al. · The American Journal of Gastroenterology · 343
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
2021 · Philippe Bégin, Jeannie Callum, et al. · Nature Medicine · 258
PDF
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
2022 · Karim Ali, Tanweer Azher, et al. · Canadian Medical Association Journal · 165
PDF
Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario
2014 · Sy-Bing Choi, Lee-Ching Lew, et al. · Critical Reviews in Biotechnology · 119
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
2026 · Sreya Duttagupta, Meriem Messaoudene, et al. · Nature Medicine · 85
PDF
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial
2022 · Kait F. Al, Laura J Craven, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 80
PDF
Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases
2017 · Laura J Craven, Seema Nair Parvathy, et al. · Open Forum Infectious Diseases · 56
PDF
Breaking down the gut microbiome composition in multiple sclerosis
2016 · Adrian Budhram, Seema Parvathy, et al. · Multiple Sclerosis Journal · 51
PDF
Dissecting mechanisms of fecal microbiota transplantation efficacy in disease
2024 · Catherine M. Andary, Kait F. Al, et al. · Trends in Molecular Medicine · 41
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial
2026 · Ricardo Fernandes, Behnam Jabbarizadeh, et al. · Nature Medicine · 38
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
2025 · Danial Khan Hadi, Kelly J Baines, et al. · Journal for ImmunoTherapy of Cancer · 36
PDF
Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma
2022 · Marina Ninkov, Crystal L. Schmerk, et al. · Cancer Immunology Immunotherapy · 32
PDF
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
2020 · Jing Ouyang, Stéphane Isnard, et al. · Frontiers in Medicine · 30
PDF
1068P Phase II trial of fecal microbiota transplantation (FMT) plus immune checkpoint inhibition (ICI) in advanced non-small cell lung cancer and cutaneous melanoma (FMT-LUMINate)
2024 · A. Elkrief, S. Duttagupta, et al. · Annals of Oncology · 22
PDF
Preventing adverse events in patients with renal cell carcinoma treated with doublet immunotherapy using fecal microbiota transplantation (FMT): Initial results from perform a phase I study.
2022 · Ricardo Fernandes, Seema Nair Parvathy, et al. · Journal of Clinical Oncology · 17
Abstract CT258: Phase II trial of fecal microbiota transplantation in combination with ipilimumab and nivolumab in patients with advanced cutaneous melanoma (FMT-LUMINate trial)
2024 · Sreya Duttagupta, Meriem Messaoudene, et al. · Cancer Research · 13
P864 Combination of fecal microbiota transplantation from healthy donors with anti-PD1 immunotherapy in treatment-naïve advanced or metastatic melanoma patients
2020 · Saman Maleki, John Lenehan, et al. · Poster presentations · 12
PDF
Fecal microbiota transplantation followed by anti–PD-1 treatment in patients with advanced melanoma.
2022 · Wilson H. Miller, Bertrand Routy, et al. · Journal of Clinical Oncology · 11
Enhanced donor screening for faecal microbial transplantation during COVID-19
2021 · Seema Nair Parvathy, John G Lenehan, et al. · Gut · 10
PDF
Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
2023 · Bertrand Routy, John G. Lenehan, et al. · Nature Medicine · 9
PDF
Abstract 2210: Microbiome profiling reveals that fecal microbiota transplantation (FMT) modulates response and toxicity when combined with immunotherapy in patients with lung cancer and melanoma (FMT-LUMINate NCT04951583)
2025 · Sreya Duttagupta, Meriem Messaoudene, et al. · Cancer Research · 7
614 Microbiome modification with fecal microbiota transplant from healthy donors before anti-PD1 therapy reduces primary resistance to immunotherapy in advanced and metastatic melanoma patients
2022 · Bertrand Routy, John Lenehan, et al. · Regular and Young Investigator Award Abstracts · 4
PDF
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
2022 · Philippe Bégin, Jeannie Callum, et al. · Nature Medicine · 4
PDF
Works count: 39
Citation count: 2,362
H-index: 17
I10-index: 21
Year
Topic
Type